Mark Allen Kemble, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 245 Parkway E, Duncan, SC 29334 Phone: 864-661-1539 Fax: 864-641-6647 |
Mr. Richard Lucarelli, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1575 E Main St, Duncan, SC 29334 Phone: 864-560-3500 Fax: 864-560-3535 |
Mr. Michael Tanbonliong, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1575 E Main St, Duncan, SC 29334 Phone: 864-560-3500 Fax: 864-560-3535 |
Antoinette Denise Rhynes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Squires Pt, Duncan, SC 29334 Phone: 864-968-5123 Fax: 864-241-9256 |
Lavare Seltun, NP Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1515 E Main St, Duncan, SC 29334 Phone: 864-984-0773 Fax: 864-984-0783 |
Dr. Clifford William Bowers Iii, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Squires Pt Ste B, Duncan, SC 29334 Phone: 864-428-9959 |
Walter Dean Kucaba, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1575 E Main St, Duncan, SC 29334 Phone: 864-560-3500 Fax: 864-560-3522 |
Mrs. Brenda Adams-hudson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1575 E Main St, Duncan, SC 29334 Phone: 864-560-3500 Fax: 864-560-3535 |
News Archive
Lpath, Inc., the category leader in lipidomics-based therapeutics, reported positive summary results of its single-dose Phase 1 clinical trial of iSONEP™ in wet-AMD patients.
UCB Canada Inc. is proud to announce the launch of the 2010 UCBeyond Scholarship Program. During its four-year lifespan, the UCBeyond Scholarship has allocated almost 70 educational bursaries worth close to $350,000.00 CAN to students living with chronic illnesses such as rheumatoid arthritis, Crohn's disease and epilepsy.
New research from the University of Birmingham has found that lower levels of antibodies in saliva are associated with of an elevated risk of mortality, and could be an early indicator of risk.
TriLink BioTechnologies, Inc. (TriLink), a leading provider of custom nucleic acid-based compounds, announced it has signed a distribution agreement permitting tebu-bio SA (tebu) to sell its CleanAmp(TM) products. tebu-bio is a European based distributor that supplies over 750,000 reagents and lab services from manufacturers worldwide.
› Verified 4 days ago